05 Mar 2015

BuTrans (Buprenorphine) - United Kingdom

ATC: N02AE
NERVOUS SYSTEM
ANALGESICS
OPIOIDS
ORIPAVINE DERIVATIVES
BuTrans

Generic Matches for Buprenorphine (5)
BUTRANS 5, 10 and 20ug/h Transdermal Patch
Temgesic Injection
Temgesic Sublingual Tablets
Transtec Transdermal Patch
SUBOXONE Sublingual Tablets

Last Updated on 05 Mar 2015 by EPG Health Media Staff

Suggest content to an epgonline.org editor - or let us know about a mistake you have spotted on this page

BuTrans Indication

Treatment of non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia.

BuTrans is not suitable for the treatment of acute pain.

 

BuTrans Generic Name

Buprenorphine

Type

POM

Summary Product Characteristics (SPCs) Links
SPC - BuTrans transdermal patch (external site)

Related Learning Zones

Prostate Cancer Learning Hub

Prostate Cancer Learning Hub

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer. The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer.

Symptomatic Asthma Knowledge Centre and CME

Symptomatic Asthma Knowledge Centre and CME

Focusing on the lack of symptomatic control in patients with asthma, the new Symptomatic Asthma Learning Zone, consisting of a Disease Awareness section and an RCGP-accredited CME, is free to access for all epgonline.org members, and has been designed to provide them with the information they need to effectively manage the symptoms of their patients with asthma.

Selected content related to BuTrans (Buprenorphine)

Journals

News

BuTrans Marketing Information

BuTrans Generic Name
Buprenorphine
Marketing Company
Napp Pharmaceuticals Limited
Drug Type
POM
Date of Issue, Marketing Authority 10/06/2005

Related Drugs - Pain Management

Back to top